Kambhampati S, Saumoy M, Schneider Y, Pak S, et al. Cost Effectiveness of Polatuzumab Vedotin Combined with Chemoimmunotherapy in Untreated Diffuse Large B-cell Lymphoma. Blood 2022 Jun 14. pii: 485545. doi: 10.1182/blood.2022016624.
PMID: 35700381